Curis | CRIS - Capitale Sociale E Riserve





Capitale Sociale E Riserve Cambiamento Data
Alaunos Therapeutics USD 2.8M 858K 2025-09
Amgen USD 8.66B 961M 2025-12
AstraZeneca USD 48.67B 2.78B 2025-12
Bayer EUR 25.95B 3.75B 2025-12
Bristol-Myers Squibb USD 18.55B 1.06B 2025-09
CSL USD 18.66B 2.75B 2025-12
Curis USD 5.46M 19.45M 2025-12
Eli Lilly USD 26.54B 2.74B 2025-12
Exelixis USD 2.16B 619K 2025-12
Gilead Sciences USD 22.62B 1.16B 2025-12
GlaxoSmithKline GBP 16.38B 229M 2025-12
Incyte USD 5.17B 516.28M 2025-12
Merck USD 51.85B 2.79B 2025-09
Novartis USD 46.13B 1.38B 2025-12
Pfizer USD 92.8B 4.11B 2025-09
Roche Holding CHF 33.8B 758M 2025-12
Sanofi EUR 71.71B 1.55B 2025-12
Takeda JPY 7.64T 513.39B 2025-12
TG Therapeutics USD 648.02M 40.8M 2025-12
Verastem USD 57.2M 72.72M 2025-12
Xoma USD 87.94M 15.5M 2025-09